Table III.
Percentage of apoptosis in experimental, sham and control groups
| Groups | Apoptosis (%) |
|---|---|
| LDND + hMG (Syn) | 48.80 ± 18.70a,f |
| HDND + hMG (Syn) | 65.20 ± 14.20a, f |
| Sham 1 (Syn) | 33.20 ± 17.80 |
| LDND + hMG (Non-Syn) | 55.80 ± 17.20b,c, f |
| HDND + hMG (Non-Syn) | 75.20 ± 14.30 b,d, f |
| Sham 2 (Non-Syn) | 31.60 ± 32.40 |
| hMG | 29.80 ± 21.80e |
| Control | 32.20 ± 16.90 |
Data presented as mean±SD.
an Increased significantly compared with the Sham 1 (p<0.01).
LDND: Low dose nandrolone decanoate
hMG: Human menopausal gonadotropins
HDND: High dose nandrolone decanoate
b
Increased significantly compared with the Sham 2 (p<0.01).
c
Increased significantly compared with the LDN+hMG (Syn) (p<0.01).
d
Increased significantly compared with the HDN+hMG (Syn) (p<0.01).
e
Decreased significantly compared with the control (p<0.01).
f
Increased significantly compared with the sham groups and control (p<0.01).